Functional Gastrointestinal Disorders (FGIDs) Support Protocol

Gastrointestinal HealthModerate Evidence
9
supplements
2
Primary
7
Supporting
2
Grade A
123
Studies

Primary Stack

Core supplements with strongest evidence
10-50 billion CFU daily (strains like B. infantis 35624, L. plantarum 299v)

Modulates gut microbiome; reduces symptoms in IBS and other FGIDs; strain-specific effects

50 studies8,000 participants
180-225mg enteric-coated capsules 2-3 times daily

Antispasmodic; reduces abdominal pain and bloating in IBS; must be enteric-coated

15 studies1,500 participants

Supporting Stack

Additional supplements for enhanced results
5-10g psyllium daily (start low, increase gradually)

Soluble fiber regulates bowel function; better tolerated than insoluble fiber in IBS

15 studies1,200 participants
5-15g daily

Supports gut barrier function; may help with leaky gut; studied for IBS-D

8 studies400 participants
Comprehensive enzyme formula with meals

May help with bloating from carbohydrate maldigestion; lactase for lactose intolerance

8 studies400 participants
250-500mg 2-4 times daily

Prokinetic; helps with nausea and gastroparesis symptoms

10 studies500 participants
320-640mg 2-3 times daily

May help with functional dyspepsia and IBS symptoms

6 studies400 participants
400-500mg 3-4 times daily

Demulcent; soothes GI tract; traditional remedy for digestive symptoms

3 studies100 participants
2000-4000 IU daily

Deficiency common in IBS; supplementation may reduce symptoms

8 studies400 participants

How This Protocol Works

Simple Explanation

Functional Gastrointestinal Disorders (FGIDs) are conditions where the GI tract doesn't function properly, but no structural abnormality is found. The most common is Irritable Bowel Syndrome (IBS), but the category includes functional dyspepsia, functional constipation, functional bloating, and others.

COMMON FGIDs:

•IBS: Abdominal pain with altered bowel habits (IBS-C, IBS-D, IBS-M)
•Functional Dyspepsia: Upper abdominal discomfort, fullness, early satiety
•Functional Constipation: Infrequent, hard stools without IBS pain
•Functional Bloating: Distension without other IBS criteria
•Functional Diarrhea: Loose stools without pain

ROME IV CRITERIA are used for diagnosis.

LIFESTYLE MANAGEMENT:

•Identify and avoid trigger foods
•Regular eating schedule
•Stress management (key trigger)
•Regular exercise
•Adequate sleep
•Low FODMAP diet (for IBS)

WHEN TO SEE A DOCTOR:

•Blood in stool
•Unexplained weight loss
•Night-time symptoms
•Fever
•New symptoms after age 50
•Family history of GI cancers

* Probiotics have the strongest evidence for IBS - specific strains like Bifidobacterium infantis 35624.

* Peppermint oil (enteric-coated) reduces abdominal pain and is recommended in guidelines.

* Psyllium fiber helps regulate bowel function.

* Ginger helps with nausea and motility.

Expected timeline: Supplements typically show benefit within 2-8 weeks. FGIDs are chronic conditions requiring ongoing management.

Clinical Perspective

Functional GI Disorders: Rome IV criteria define; disorders of gut-brain interaction. Most common: IBS (affects 10-15% of population). Pathophysiology: visceral hypersensitivity, altered motility, gut microbiome dysbiosis, brain-gut axis dysfunction. Subtypes: IBS-C, IBS-D, IBS-M. Functional dyspepsia: EPS (epigastric pain syndrome), PDS (postprandial distress syndrome). Diagnosis: symptom-based criteria; limited testing for red flags.

CRITICAL: Rule out red flags (alarm symptoms). Rome IV criteria for positive diagnosis. Multifaceted approach: diet (low FODMAP for IBS), lifestyle, psychological therapies (CBT, gut-directed hypnotherapy), medications as needed. Probiotics and peppermint oil have guideline-level evidence for IBS. Avoid unnecessary testing and polypharmacy.

* Probiotics (A-grade): Strain-specific effects. Meta-analysis: (PMID: 29882905). Cochrane: (PMID: 25007694). B. infantis 35624, L. plantarum 299v. 10-50 billion CFU daily.

* Peppermint Oil (A-grade): Antispasmodic. Meta-analysis: (PMID: 27841938). 180-225mg enteric-coated TID. ACG guideline recommendation.

* Psyllium (B-grade): Soluble fiber preferred. Systematic review: (PMID: 25623152). 5-10g daily. Insoluble fiber may worsen.

* L-Glutamine (B-grade): Gut barrier. Review: (PMID: 29430697). 5-15g daily. Evidence growing.

* Digestive Enzymes (C-grade): Carbohydrate maldigestion. Review: (PMID: 28332116). With meals.

* Ginger (B-grade): Prokinetic; nausea. Systematic review: (PMID: 27841938). 250-500mg 2-4x daily.

* Artichoke Extract (B-grade): Functional dyspepsia. Review: (PMID: 26182896). 320-640mg 2-3x daily.

* Slippery Elm (C-grade): Demulcent. Pilot: (PMID: 19192328). 400-500mg 3-4x daily.

* Vitamin D (B-grade): Common deficiency in IBS. Meta-analysis: (PMID: 28750270). 2000-4000 IU daily.

Assessment targets: Symptom diaries, Rome IV criteria, quality of life scales (IBS-QOL), dietary triggers.

Protocol notes: Low FODMAP: evidence-based diet for IBS; 2-6 week elimination then reintroduction; dietitian guidance ideal. Psychological: CBT, gut-directed hypnotherapy effective; address stress and anxiety. Medications: IBS-D (loperamide, rifaximin, eluxadoline), IBS-C (linaclotide, lubiprostone), antispasmodics, low-dose TCAs/SSRIs. Probiotics: not all equal; strain matters; try for 4-8 weeks. Fiber: start low, go slow; psyllium better than wheat bran. SIBO: consider if bloating, flatulence prominent; breath testing. Bile acid malabsorption: consider in IBS-D; bile acid sequestrants. Pelvic floor dysfunction: consider in constipation; biofeedback effective. Patient education: explain brain-gut axis; validate symptoms. Avoid: unnecessary antibiotics, excessive testing, opioids.